The emerging approach of this peptide represents a major development in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and GIP – leading to https://tirzepatide-peptide179678.acidblog.net/73375338/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment